Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.61 AUD | -1.61% | -8.27% | +14.02% |
May. 15 | Recce Pharmaceuticals Doses First Patient in Urosepsis Rapid Infusion Clinical Trial | MT |
May. 10 | Recce Pharmaceuticals Finds 'Promising' Results From Nebulized RECCE 327 Pilot Study | MT |
- Stock Market
- Equities
- RCE Stock
- News Recce Pharmaceuticals Ltd